tricalcium phosphate has been researched along with Osteomyelitis in 71 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (5.63) | 18.7374 |
| 1990's | 2 (2.82) | 18.2507 |
| 2000's | 20 (28.17) | 29.6817 |
| 2010's | 38 (53.52) | 24.3611 |
| 2020's | 7 (9.86) | 2.80 |
| Authors | Studies |
|---|---|
| Bostrom, MPG; Boyle, KK; Osagie, L; Sosa, B; Turajane, K; Yang, X | 1 |
| Abdeltawab, NF; Awad, GAS; Ishak, RAH; Nasr, M; Radwan, NH | 1 |
| Huchital, MJ; Patel, R; Saleh, A; Subik, M | 1 |
| Asfuroğlu, ZM; Doğan, A; Gürbüz, M; Köse, A; Köse, N; Şahintürk, V | 1 |
| Ballay, R; Čeřovský, V; Fulín, P; Jahoda, D; Landor, I; Melicherčík, P; Nešuta, O | 1 |
| Dold, A; Perretta, D; Youm, T | 1 |
| Chang, F; Chen, G; Ding, J; Liu, B; Liu, H; Wang, Q; Yang, K; Zhang, H | 1 |
| Abba, Y; Karunanidhi, A; Lulu, GA; Mohamad Yusof, L; Mohd Fauzi, F; Othman, F | 1 |
| Canal, C; Fernandez-Yague, MA; Ginebra, MP; Manzanares-Céspedes, MC; Mestres, G; Montufar, EB; Pastorino, D | 1 |
| Desai, TA; Uskoković, V | 4 |
| Chia, WT; Chung, MF; Hsiao, CW; Hsiao, HC; Liu, HY; Sung, HW; Yang, CM | 1 |
| Cohen, V; Gotman, I; Makarov, C; Raz-Pasteur, A | 1 |
| Ito, A; Mutsuzaki, H; Oyane, A; Sakane, M; Sogo, Y; Yamazaki, M | 1 |
| Iwakura, T; Kuroda, R; Kurosaka, M; Lee, SY; Miwa, M; Niikura, T; Nishida, K; Sakai, Y | 1 |
| Ben-Nissan, B; Cazalbou, S; Choi, AH; Macha, I | 1 |
| Iwakura, T; Kuroda, R; Kurosaka, M; Lee, SY; Niikura, T; Sakai, Y | 1 |
| Bettencourt, A; Ferreira, JM; Gonçalves, LM; Marques, CF; Matos, AC; Ribeiro, IA | 1 |
| Chanda, A; Datta, S; Joy, M; Kundu, B; Maitra, NJ; Mistry, S; Roy, S | 1 |
| Chen, HW; Huang, HB; Ji, XR; Zhao, GS | 1 |
| Amador, G; Bouler, JM; Gautier, H; Merle, C; Plumecocq, A; Weiss, P | 1 |
| Gbureck, U; Kissel, T; Schnieders, J; Schossig, M; Vorndran, E | 1 |
| Buckley, RE; Seadon, S | 1 |
| Brandt, B; Diederichs, S; Frebel, T; Joist, A; Joosten, U; von Eiff, C | 1 |
| Efstathopoulos, N; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kanellakopoulou, K; Kapranou, A; Lazarettos, J; Nikolaou, V; Papachristou, G; Papagelopoulos, PJ; Papalois, A; Savvidou, OD | 1 |
| Buxton, TB; Hartmann, JF; Harvey, SB; McPherson, JC; Plowman, KM; Walsh, DS | 1 |
| Ahmed, K; El-Ghannam, A; Omran, M | 1 |
| Kisanuki, O; Takakura, Y; Umeda, T; Yajima, H | 1 |
| Amerongen, AV; de Roo, R; Faber, C; Stallmann, HP; Wuisman, PI | 1 |
| Kent, JN; Zide, MF | 1 |
| Ishii, Y; Sasaki, S | 1 |
| Evora, C; Soriano, I | 1 |
| Boguń, M; Chłopek, J; Domalik-Pyzik, P; Kucharski, R; Mielczarek, P; Morawska-Chochół, A; Rzewuska, M; Sterna, J; Szaraniec, B | 1 |
| Applbaum, YH; Barenholz, Y; Cohen, O; Emanuel, N; Rosenfeld, Y; Segal, D | 1 |
| Abdullah, A; DiCicco, M; Goldfinger, A; Guirand, F; Jansen, SA | 1 |
| Alvarez, H; Castro, C; Delgado, A; Evora, C; Moujir, L; Perera, A; Sánchez, E; Soriano, I | 1 |
| Eitenmüller, J; Gellissen, G; Golsong, W; Peters, G; Reichmann, W; Weltin, R | 2 |
| Cathelineau, G; Lambotte, JC; Lancien, G; Langlais, F; Minet, J; Thomazeau, H | 1 |
| Decker, S | 1 |
| Kawano, H; Miyamoto, W; Morimoto, S; Sasaki, G; Watanabe, Y; Yasui, Y | 1 |
| Cambou, L; Canavese, F; Ghanem, I; Mansour, M; Pereira, B; Rousset, M; Samba, A; Walle, M | 1 |
| Careri, S; Maccauro, G; Oliva, MS; Perisano, C; Vitiello, R; Ziranu, A | 1 |
| Chen, Q; Fan, X; He, X; Huang, M; Li, F; Liu, H; Wang, Y; Wen, Y; Xu, Y; Yang, D; Zhou, T | 1 |
| Bilgic, E; Kankilic, B; Korkusuz, F; Korkusuz, P | 1 |
| Ito, A; Kimishima, K; Makiishi, J; Matsuno, T; Satoh, T; Sogo, Y; Tamazawa, G | 1 |
| Benghuzzi, H; Cleary, JD; Nguyen, C; Sealy, PI; Tucci, M | 1 |
| Bormann, KH; Essig, H; Gellrich, NC; Kokemueller, H; Nolff, M; Rücker, M; Spalthoff, S; Stuehmer, C; Tavassol, F | 1 |
| Ding, J; Li, J; Shi, J; Xu, YQ; Zhu, CT | 1 |
| Ito, A; Kimishima, K; Kitahara, K; Matsuno, T; Miyai, T; Satoh, T; Sogo, Y; Tamazawa, G | 1 |
| Dong, J; Fang, T; Wang, Y; Zhou, J | 1 |
| Dong, J; Fang, T; Shao, Z; Wen, J; Zhou, J | 1 |
| Ito, A; Matsuno, T; Miyai, T; Nakamura, C; Satoh, T; Sogo, Y; Tamazawa, G; Yamazaki, A | 1 |
| Bernstein, A; Bohner, M; Kuehling, T; Mayr, HO; Schilling, P; Seidenstuecker, M; Serr, A; Wittmer, A | 1 |
| Liu, S; Liu, Y; Luo, W; Wang, G; Zhang, Y; Zhao, Z; Zhou, Y | 1 |
| Fan, T; Feng, F; Guo, J; Hu, Y; Li, Y; Li, Z; Liu, J; Liu, L; Liu, Y; Luo, X; Ma, T; Tian, Y; Wang, X; Wang, Y; Yang, Y; Zhang, X | 1 |
| Guo, Q; Lang, ZG; Liang, YX; Yuan, F; Zhang, X | 1 |
| Comeau, P; Filiaggi, M | 1 |
| Desai, TA; Hoover, C; Uskoković, DP; Uskoković, V; Vukomanović, M | 1 |
| Comeau, PA; Filiaggi, MJ | 1 |
| Caley, R; Gbureck, U; Grover, LM; Jiang, PJ; Patel, S | 1 |
| Bronckers, AL; Faber, C; Nieuw Amerongen, AV; Stallmann, HP; Wuisman, PI | 1 |
| Faber, C; Joosten, U; Lyaruu, DM; Stallmann, HP; van Nieuw Amerongen, A; von Eiff, C; Wuisman, PI | 1 |
| Dion, A; Filiaggi, M; Hall, G; Langman, M | 1 |
| Ishibashi, Y; Katano, H; Nagumo, A; Sasaki, T; Toh, S | 1 |
| Athanassiou, K; Giamarellou, H; Kanellakopoulou, K; Koutoukas, P; Raftogiannis, M; Skiadas, I; Tsaganos, T | 1 |
| Kurosaka, M; Niikura, T; Shiba, R; Tadokoro, K; Tsujimoto, K; Yoshiya, S | 1 |
| Filiaggi, MJ; Hall, G; Langman, M; Petrone, C | 1 |
| Konttinen, YT; Lassus, J; Santavirta, S; Tulikoura, I | 1 |
6 review(s) available for tricalcium phosphate and Osteomyelitis
| Article | Year |
|---|---|
Cancelloplasty for Treatment of Osteomyelitis of the Calcaneus: A Novel Technique and Case Report.
Topics: Amputation, Surgical; Anti-Bacterial Agents; Bone Substitutes; Calcaneus; Calcium Phosphates; Diabetic Foot; Gentamicins; Humans; Male; Middle Aged; Osteomyelitis; Osteotomy; Plastic Surgery Procedures; Postoperative Care; Surgery, Computer-Assisted; Treatment Outcome; Ultrasonography; Vancomycin | 2021 |
Nanoparticulate drug delivery platforms for advancing bone infection therapies.
Topics: Animals; Anti-Bacterial Agents; Calcium Phosphates; Drug Carriers; Humans; Nanocomposites; Osteomyelitis; Polymers; Tissue Engineering | 2014 |
Calcium phosphate nanocoatings and nanocomposites, part 2: thin films for slow drug delivery and osteomyelitis.
Topics: Bone Regeneration; Calcium Phosphates; Coated Materials, Biocompatible; Drug Delivery Systems; Durapatite; Humans; Nanocomposites; Osteomyelitis | 2016 |
[Treatment of chronic osteomyelitis with antibiotic-loaded calcium phosphate cement].
Topics: Anti-Bacterial Agents; Bone Cements; Calcium Phosphates; Chronic Disease; Humans; Osteomyelitis | 2008 |
Wound healing: bone and biomaterials.
Topics: Biocompatible Materials; Biomechanical Phenomena; Calcium Phosphates; Ceramics; Facial Bones; Humans; Hydroxyapatites; Ilium; Mandibular Fractures; Maxillary Fractures; Osteomyelitis; Osteoradionecrosis; Prostheses and Implants; Ribs; Skull Fractures; Temporomandibular Joint; Temporomandibular Joint Disorders; Wound Healing | 1984 |
Masquelet technique and osteomyelitis: innovations and literature review.
Topics: Bone Substitutes; Bone Transplantation; Calcium Phosphates; Humans; Osteomyelitis; Plastic Surgery Procedures | 2019 |
2 trial(s) available for tricalcium phosphate and Osteomyelitis
| Article | Year |
|---|---|
Topics: Anti-Bacterial Agents; Bone Cements; Bone Morphogenetic Protein 2; Bone Screws; Calcium Phosphates; Femoral Neck Fractures; Femur Neck; Fracture Fixation, Internal; Humans; Osteomyelitis; Prospective Studies; Retrospective Studies; Single-Blind Method; Treatment Outcome | 2021 |
Clinical observations of vancomycin-loaded calcium phosphate cement in the 1-stage treatment of chronic osteomyelitis: a randomized trial.
Topics: Anti-Bacterial Agents; Bone Cements; Calcium Phosphates; Humans; Osteomyelitis; Vancomycin | 2021 |
63 other study(ies) available for tricalcium phosphate and Osteomyelitis
| Article | Year |
|---|---|
Vancomycin-laden calcium phosphate-calcium sulfate composite allows bone formation in a rat infection model.
Topics: Animals; Biocompatible Materials; Calcium Phosphates; Calcium Sulfate; Disease Models, Animal; Humans; Male; Osteogenesis; Osteomyelitis; Polymethyl Methacrylate; Random Allocation; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; X-Ray Microtomography | 2019 |
Chitosan-calcium phosphate composite scaffolds for control of post-operative osteomyelitis: Fabrication, characterization, and in vitro-in vivo evaluation.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Calcium Phosphates; Cell Line; Chitosan; Drug Carriers; Humans; Moxifloxacin; Osteoblasts; Osteomyelitis; Rabbits; Tissue Scaffolds | 2020 |
Silver ion-doped calcium phosphate-based bone-graft substitute eliminates chronic osteomyelitis: An experimental study in animals.
Topics: Animals; Anti-Bacterial Agents; Bone Substitutes; Calcium Phosphates; Chronic Disease; Male; Osteomyelitis; Rabbits; Random Allocation; Silver; Vancomycin | 2021 |
Testing the efficacy of antimicrobial peptides in the topical treatment of induced osteomyelitis in rats.
Topics: Animals; Anti-Bacterial Agents; Calcium Phosphates; Humans; Male; Osteomyelitis; Peptides; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus | 2018 |
Osteomyelitis After Calcium Phosphate Subchondroplasty A Case Report.
Topics: Arthroplasty, Subchondral; Bone Marrow Diseases; Bone Substitutes; Calcium Phosphates; Humans; Male; Middle Aged; Osteomyelitis; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus | 2017 |
Calcium Phosphate Cement loaded with 10% vancomycin delivering high early and late local antibiotic concentration in vitro.
Topics: Anti-Bacterial Agents; Bone Cements; Calcium Phosphates; Compressive Strength; Delayed-Action Preparations; Drug Carriers; In Vitro Techniques; Materials Testing; Microbial Sensitivity Tests; Osteomyelitis; Staphylococcus aureus; Vancomycin | 2018 |
In vivo efficacy of tobramycin-loaded synthetic calcium phosphate beads in a rabbit model of staphylococcal osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Calcium Phosphates; Disease Models, Animal; Drug Delivery Systems; Humans; Male; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 2018 |
In vivo efficiency of antimicrobial inorganic bone grafts in osteomyelitis treatments.
Topics: Animals; Anti-Bacterial Agents; Bone Cements; Bone Diseases, Infectious; Bone Regeneration; Calcium Phosphates; Doxycycline; Drug Delivery Systems; Drug Implants; Drug Liberation; Female; Femur; Osteomyelitis; Porosity; Rabbits; Staphylococcal Infections; Treatment Outcome; Viscoelastic Substances | 2019 |
Calcium phosphate nanoparticles: a future therapeutic platform for the treatment of osteomyelitis?
Topics: Calcium Phosphates; Drug Delivery Systems; Humans; Nanoparticles; Osteomyelitis | 2013 |
Inflammation-induced drug release by using a pH-responsive gas-generating hollow-microsphere system for the treatment of osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bone Cements; Calcium Phosphates; Carbon Dioxide; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Gases; Hydrogen-Ion Concentration; Inflammation; Lactic Acid; Microspheres; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Vancomycin | 2014 |
In vitro elution of vancomycin from biodegradable osteoconductive calcium phosphate-polycaprolactone composite beads for treatment of osteomyelitis.
Topics: Anti-Bacterial Agents; Calcium Phosphates; Chromatography, High Pressure Liquid; Drug Carriers; Drug Liberation; Drug Stability; Mass Spectrometry; Microbial Sensitivity Tests; Nanocomposites; Osteomyelitis; Polyesters; Pressure; Solubility; Staphylococcus aureus; Vancomycin | 2014 |
The calcium phosphate matrix of FGF-2-apatite composite layers contributes to their biological effects.
Topics: Animals; Apatites; Bone and Bones; Bone Nails; Calcium Phosphates; Coated Materials, Biocompatible; Escherichia coli; Fibroblast Growth Factor 2; Inflammation; Male; Mice; NIH 3T3 Cells; Osteomyelitis; Rabbits; Staphylococcus aureus; Titanium | 2014 |
Gentamycin-impregnated calcium phosphate cement for calcaneal osteomyelitis: a case report.
Topics: Anti-Bacterial Agents; Bone Cements; Calcaneus; Calcium Phosphates; Diabetic Foot; Female; Gentamicins; Humans; Middle Aged; Osteomyelitis | 2014 |
Antibiotic-impregnated calcium phosphate cement as part of a comprehensive treatment for patients with established orthopaedic infection.
Topics: Adult; Aged; Anti-Bacterial Agents; Bone Cements; Calcium Phosphates; Female; Follow-Up Studies; Fractures, Ununited; Humans; Male; Middle Aged; Osteomyelitis; Proteus Infections; Proteus mirabilis; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Young Adult | 2016 |
Insights on the properties of levofloxacin-adsorbed Sr- and Mg-doped calcium phosphate powders.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Biopolymers; Calcium Phosphates; Cell Line; Chromatography, High Pressure Liquid; Escherichia coli; Humans; Levofloxacin; Magnesium; Mice; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Osteomyelitis; Powders; Spectroscopy, Fourier Transform Infrared; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Strontium; X-Ray Diffraction | 2016 |
A novel, multi-barrier, drug eluting calcium sulfate/biphasic calcium phosphate biodegradable composite bone cement for treatment of experimental MRSA osteomyelitis in rabbit model.
Topics: Absorbable Implants; Animals; Bone Cements; Calcium Phosphates; Calcium Sulfate; Disease Models, Animal; Humans; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Rabbits; Staphylococcal Infections; Treatment Outcome; X-Ray Diffraction | 2016 |
In vitro characterization of calcium phosphate biomaterial loaded with linezolid for osseous bone defect implantation.
Topics: Acetamides; Anti-Infective Agents; Apatites; Biocompatible Materials; Calcium Phosphates; Drug Carriers; Humans; Linezolid; Osteomyelitis; Oxazolidinones | 2012 |
The effect of porosity on drug release kinetics from vancomycin microsphere/calcium phosphate cement composites.
Topics: Anti-Bacterial Agents; Bone Cements; Calcium Phosphates; Drug Delivery Systems; Humans; Hydroxyapatites; Kinetics; Microscopy, Electron, Scanning; Microspheres; Osteomyelitis; Porosity; Powders; Staphylococcus aureus; Vancomycin | 2011 |
Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. II. Antibacterial and osteoblastic response.
Topics: 3T3 Cells; Animals; Anti-Bacterial Agents; Calcium Phosphates; Clindamycin; Delayed-Action Preparations; Humans; Mice; Nanoparticles; Osteoblasts; Osteomyelitis; Solubility; Staphylococcal Infections; Staphylococcus aureus | 2013 |
Infections in calcaneal fracture patients treated with open reduction and internal fixation and bioresorbable calcium phosphate paste: a case series.
Topics: Anti-Bacterial Agents; Bone Substitutes; Calcaneus; Calcium Phosphates; Debridement; Disability Evaluation; Fracture Fixation, Internal; Fractures, Bone; Humans; Male; Middle Aged; Osteomyelitis; Pain Measurement; Postoperative Complications; Retrospective Studies; Therapeutic Irrigation | 2012 |
Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamicin in the treatment of chronic osteomyelitis: studies in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Calcium Phosphates; Chronic Disease; Compressive Strength; Diffusion; Drug Carriers; Drug Evaluation, Preclinical; Gentamicins; Injections; Osteomyelitis; Rabbits; Staphylococcal Infections; Treatment Outcome | 2004 |
A bioresorbable calcium phosphate delivery system with teicoplanin for treating MRSA osteomyelitis.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Calcium Phosphates; Drug Delivery Systems; Male; Methicillin Resistance; Osteomyelitis; Rabbits; Staphylococcal Infections; Teicoplanin | 2004 |
Bisphosphonate-ciprofloxacin bound to Skelite is a prototype for enhancing experimental local antibiotic delivery to injured bone.
Topics: Animals; Anti-Infective Agents; Calcium Phosphates; Ciprofloxacin; Diphosphonates; Drug Carriers; Drug Combinations; Osteomyelitis; Rats; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Tibial Fractures | 2004 |
Nanoporous delivery system to treat osteomyelitis and regenerate bone: gentamicin release kinetics and bactericidal effect.
Topics: Anti-Bacterial Agents; Apatites; Bone Regeneration; Calcium Phosphates; Drug Delivery Systems; Gentamicins; Hydrogen-Ion Concentration; Kinetics; Materials Testing; Osteomyelitis; Silicon Dioxide; Surface Properties | 2005 |
Experimental study of calcium phosphate cement impregnated with dideoxy-kanamycin B.
Topics: Anti-Bacterial Agents; Bone Cements; Calcium Phosphates; Compressive Strength; Dibekacin; Drug Combinations; Drug Compounding; Humans; Osteomyelitis | 2007 |
In vivo release of the antimicrobial peptide hLF1-11 from calcium phosphate cement.
Topics: Animals; Antimicrobial Cationic Peptides; Bone Cements; Calcium Phosphates; Drug Delivery Systems; Female; Humans; Lactoferrin; Osteomyelitis; Peptide Fragments; Prosthesis Implantation; Rabbits | 2008 |
Apatite cement containing antibiotics: efficacy in treating experimental osteomyelitis.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Apatites; Bone Cements; Bone Marrow; Bone Transplantation; Calcium Phosphates; Curettage; Delayed-Action Preparations; Disease Models, Animal; Disease Progression; Drug Delivery Systems; Female; Gentamicins; Lactic Acid; Osteogenesis; Osteomyelitis; Polyesters; Polymers; Rabbits; Staphylococcal Infections; Therapeutic Irrigation; Tibia | 1999 |
Formulation of calcium phosphates/poly (d,l-lactide) blends containing gentamicin for bone implantation.
Topics: Absorbable Implants; Calcium Phosphates; Drug Delivery Systems; Gentamicins; Hydroxyapatites; Osteomyelitis; Periosteum; Polymers | 2000 |
Gentamicin release from biodegradable poly-l-lactide based composites for novel intramedullary nails.
Topics: Alginates; Alloys; Anti-Bacterial Agents; Biocompatible Materials; Bone Nails; Calcium Phosphates; Gentamicins; Glucuronic Acid; Hexuronic Acids; Humans; Microscopy, Electron, Scanning; Osteomyelitis; Polyesters; Prostheses and Implants; Staphylococcus | 2014 |
A lipid-and-polymer-based novel local drug delivery system--BonyPid™: from physicochemical aspects to therapy of bacterially infected bones.
Topics: Animals; Anti-Bacterial Agents; Calcium Phosphates; Chemical Phenomena; Coated Materials, Biocompatible; Delayed-Action Preparations; Doxycycline; Drug Compounding; Drug Delivery Systems; Drug Stability; Female; Lactic Acid; Microbial Sensitivity Tests; Osteomyelitis; Phosphatidylcholines; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Radiography; Staphylococcal Infections; Staphylococcus aureus | 2012 |
In vitro tobramycin elution analysis from a novel beta-tricalcium phosphate-silicate-xerogel biodegradable drug-delivery system.
Topics: Anti-Bacterial Agents; Benzoates; Biocompatible Materials; Bone Substitutes; Calcium Carbonate; Calcium Phosphates; Drug Delivery Systems; Gels; Humans; Hydroxyapatites; Materials Testing; Molecular Structure; Osteomyelitis; Quinolines; Reproducibility of Results; Silicates; Tobramycin | 2004 |
Efficacy of ciprofloxacin implants in treating experimental osteomyelitis.
Topics: Absorbable Implants; Animals; Anti-Infective Agents; Biocompatible Materials; Blood Platelets; Body Weight; Calcium Phosphates; Ciprofloxacin; Disease Models, Animal; Durapatite; Femur; Gamma Rays; Humans; Implants, Experimental; Leukocytes; Male; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2008 |
[Delay in the liberation of the polyvinylpyrrolidone iodine complex from porous, resorbable tricalcium phosphate ceramic granules by using soluble coatings in the local treatment of osteomyelitis. An animal experiment study].
Topics: Animals; Calcium Phosphates; Delayed-Action Preparations; Dogs; Femoral Fractures; Osteomyelitis; Povidone; Povidone-Iodine; Tibial Fractures; Wound Healing | 1984 |
[Release delay of various antibiotics from resorbable tricalcium phosphate ceramic granules with soluble coating for local treatment of osteomyelitis. An animal experiment study].
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Calcium Phosphates; Cloxacillin; Dogs; Drug Implants; Floxacillin; Fosfomycin; Osteomyelitis; Tibia | 1983 |
[Tricalcium phosphate, an antibiotic carrier: a study focused on experimental osteomyelitis in rabbits].
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone Substitutes; Calcium Phosphates; Ceramics; Colony Count, Microbial; Debridement; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Implants; Gentamicins; Humans; Osteomyelitis; Porosity; Rabbits; Random Allocation; Sheep; Staphylococcal Infections; Staphylococcus aureus; Tibia | 1998 |
[Repair of infected bony defects using calcium phosphate ceramic implants in animals].
Topics: Animals; Biocompatible Materials; Calcium Phosphates; Ceramics; Dogs; Osteitis; Osteomyelitis; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Ulna | 1985 |
Induced membrane technique using beta-tricalcium phosphate for reconstruction of femoral and tibial segmental bone loss due to infection: technical tips and preliminary clinical results.
Topics: Adult; Aged; Autografts; Bone Regeneration; Bone Substitutes; Bone Transplantation; Calcium Phosphates; Female; Femur; Fracture Fixation, Internal; Fractures, Ununited; Humans; Male; Middle Aged; Osteomyelitis; Retrospective Studies; Tibia; Transplantation, Autologous; Young Adult | 2018 |
Chronic infection and infected non-union of the long bones in paediatric patients: preliminary results of bone versus beta-tricalcium phosphate grafting after induced membrane formation.
Topics: Adolescent; Anti-Bacterial Agents; Bone Cements; Bone Substitutes; Bone Transplantation; Calcium Phosphates; Child; Child, Preschool; Chronic Disease; Debridement; Female; Follow-Up Studies; Fracture Fixation, Internal; Fracture Healing; Fractures, Ununited; Humans; Male; Osteomyelitis; Plastic Surgery Procedures; Retrospective Studies; Treatment Outcome | 2018 |
[Cationic liposome ceftazidime combined with nano-hydroxyapatite/beta-tricalcium phosphate for treatment of chronic osteomyelitis of rabbits].
Topics: Animals; Calcium Phosphates; Ceftazidime; Chronic Disease; Debridement; Disease Models, Animal; Female; Hydroxyapatites; Liposomes; Male; Nanostructures; Osteomyelitis; Rabbits; Staphylococcal Infections; Tibia; Tissue Scaffolds | 2013 |
Vancomycin containing PLLA/β-TCP controls experimental osteomyelitis in vivo.
Topics: Animals; Bone Development; Bone-Implant Interface; Calcium Phosphates; Lactic Acid; Male; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Polyesters; Polymers; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Tibia; Tissue Scaffolds; Vancomycin | 2014 |
Effects of gatifloxaine content in gatifloxacine-loaded PLGA and β-tricalcium phosphate composites on efficacy in treating osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Biocompatible Materials; Calcium Phosphates; Chromatography, High Pressure Liquid; Fluoroquinolones; Gatifloxacin; Hydrogen-Ion Concentration; Mandible; Osteogenesis; Osteomyelitis; Polyesters; Rabbits; Streptococcus milleri Group | 2016 |
Delivery of antifungal agents using bioactive and nonbioactive bone cements.
Topics: Animals; Antifungal Agents; Biocompatible Materials; Bone Cements; Calcium; Calcium Phosphates; Cattle; Cells, Cultured; Delayed-Action Preparations; Drug Carriers; Humans; Hydroxyapatites; In Vitro Techniques; Osteoblasts; Osteomyelitis; Polymethyl Methacrylate | 2009 |
Prefabrication of vascularized bioartificial bone grafts in vivo for segmental mandibular reconstruction: experimental pilot study in sheep and first clinical application.
Topics: Animals; Bioartificial Organs; Biocompatible Materials; Bone and Bones; Bone Marrow; Bone Matrix; Bone Transplantation; Calcium Phosphates; Female; Humans; Male; Mandible; Mandibular Diseases; Middle Aged; Muscle, Skeletal; Neovascularization, Physiologic; Ossification, Heterotopic; Osteoblasts; Osteogenesis; Osteomyelitis; Pilot Projects; Plastic Surgery Procedures; Sheep; Tissue and Organ Harvesting; Tissue Engineering | 2010 |
Liposome combined porous beta-TCP scaffold: preparation, characterization, and anti-biofilm activity.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Anti-Bacterial Agents; Biofilms; Calcium Phosphates; Cholesterol; Delayed-Action Preparations; Diffusion; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Gentamicins; Kinetics; Liposomes; Models, Chemical; Osteomyelitis; Particle Size; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Tissue Scaffolds | 2010 |
Gatifloxacine-loaded PLGA and β-tricalcium phosphate composite for treating osteomyelitis.
Topics: Absorbable Implants; Animals; Anti-Infective Agents; Bacteriological Techniques; Bacteroides fragilis; Bacteroides Infections; Biocompatible Materials; Calcium Phosphates; Debridement; Delayed-Action Preparations; Drug Carriers; Fluoroquinolones; Gatifloxacin; Lactic Acid; Mandibular Diseases; Materials Testing; Osteogenesis; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Rabbits; Streptococcal Infections; Streptococcus milleri Group; Tissue Distribution; Tissue Scaffolds | 2011 |
The controlled release of vancomycin in gelatin/β-TCP composite scaffolds.
Topics: Animals; Anti-Bacterial Agents; Calcium Phosphates; Delayed-Action Preparations; Gelatin; Humans; Osteomyelitis; Porosity; Rats; Rats, Sprague-Dawley; Tissue Scaffolds; Vancomycin | 2012 |
Poly (ε-caprolactone) coating delays vancomycin delivery from porous chitosan/β-tricalcium phosphate composites.
Topics: Anti-Bacterial Agents; Bone Cements; Calcium Phosphates; Chitosan; Delayed-Action Preparations; Fractures, Open; Humans; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Polyesters; Porosity; Staphylococcal Infections; Time Factors; Vancomycin | 2012 |
Antibiotic-loaded poly-epsilon-caprolactone and porous beta-tricalcium phosphate composite for treating osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Calcium Phosphates; Fluoroquinolones; Gatifloxacin; Male; Osteomyelitis; Polyesters; Porosity; Rabbits | 2008 |
A human bone infection organ model for biomaterial research.
Topics: Alginates; Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone and Bones; Calcium Phosphates; Clindamycin; Gelatin; Humans; Hydrogels; Osteomyelitis; Staphylococcus aureus | 2022 |
The effect of calcium sulfate/calcium phosphate composite for the treatment of chronic osteomyelitis compared with calcium sulfate.
Topics: Calcium Phosphates; Calcium Sulfate; Chronic Disease; Debridement; Humans; Osteomyelitis; Retrospective Studies | 2020 |
A two-stage cold isostatic pressing and gelling approach for fabricating a therapeutically loaded amorphous calcium polyphosphate local delivery system.
Topics: Anti-Bacterial Agents; Calcium Phosphates; Drug Delivery Systems; Drug Liberation; Gels; Humans; Osteomyelitis; Polyphosphates; Porosity; Strontium; Vancomycin | 2017 |
Osteogenic and antimicrobial nanoparticulate calcium phosphate and poly-(D,L-lactide-co-glycolide) powders for the treatment of osteomyelitis.
Topics: Animals; Anti-Infective Agents; Calcium Phosphates; Cell Line; Clindamycin; Collagen Type I; Core Binding Factor Alpha 1 Subunit; Hydrogen-Ion Concentration; Lactic Acid; Mice; Nanoparticles; Osteoblasts; Osteocalcin; Osteogenesis; Osteomyelitis; Osteopontin; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Staphylococcus aureus | 2013 |
Structural analysis of xSrO-(50 - x)CaO-50P2O5 glasses with x=0, 5, or 10 mol% for potential use in a local delivery system for osteomyelitis treatment.
Topics: Calcium Phosphates; Delayed-Action Preparations; Drug Delivery Systems; Glass; Humans; Osteomyelitis; Strontium; Vancomycin | 2016 |
Comparing the efficacy of three bioceramic matrices for the release of vancomycin hydrochloride.
Topics: Apatites; Biocompatible Materials; Calcium Phosphates; Ceramics; Delayed-Action Preparations; Drug Delivery Systems; Gels; Humans; Hydrogen-Ion Concentration; Hydroxyapatites; In Vitro Techniques; Materials Testing; Osteomyelitis; Prostheses and Implants; Spectroscopy, Fourier Transform Infrared; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; X-Ray Diffraction | 2010 |
Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. I. Preparation and drug release.
Topics: Anti-Bacterial Agents; Calcium Phosphates; Delayed-Action Preparations; Durapatite; Humans; Nanoparticles; Osteomyelitis | 2013 |
Osteomyelitis prevention in rabbits using antimicrobial peptide hLF1-11- or gentamicin-containing calcium phosphate cement.
Topics: Abscess; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bone Cements; Calcium Phosphates; Colony Count, Microbial; Drug Carriers; Female; Femur; Gentamicins; Lactoferrin; Methicillin Resistance; Necrosis; Osteogenesis; Osteomyelitis; Peptide Fragments; Rabbits | 2004 |
Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model.
Topics: Animals; Anti-Bacterial Agents; Bone Cements; Calcium Phosphates; Chronic Disease; Disease Models, Animal; Drug Carriers; Female; Gentamicins; Humans; Lactoferrin; Methicillin Resistance; Osteomyelitis; Peptide Fragments; Rabbits; Radiography; Staphylococcal Infections; Staphylococcus aureus; Tibia; Treatment Outcome | 2005 |
Vancomycin release behaviour from amorphous calcium polyphosphate matrices intended for osteomyelitis treatment.
Topics: Anti-Bacterial Agents; Bone Substitutes; Calcium Phosphates; Cell Survival; Coated Materials, Biocompatible; Delayed-Action Preparations; Diffusion; Humans; Materials Testing; Molecular Conformation; Osteomyelitis; Staphylococcus aureus; Vancomycin | 2005 |
In vitro elution of vancomycin from calcium phosphate cement.
Topics: Adult; Anti-Bacterial Agents; Bone Cements; Calcium Phosphates; Female; Hip Prosthesis; Humans; In Vitro Techniques; Osteomyelitis; Prosthesis-Related Infections; Vancomycin | 2005 |
Comparative elution of moxifloxacin from Norian skeletal repair system and acrylic bone cement: an in vitro study.
Topics: Absorbable Implants; Anti-Bacterial Agents; Aza Compounds; Bone Cements; Calcium Phosphates; Chromatography, High Pressure Liquid; Drug Carriers; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Osteomyelitis; Quinolines | 2006 |
Vancomycin-impregnated calcium phosphate cement for methicillin-resistant Staphylococcus aureus femoral osteomyelitis.
Topics: Adult; Anti-Bacterial Agents; Bone Cements; Calcium Phosphates; Chondroitin Sulfates; Femoral Fractures; Femur; Fracture Fixation, Intramedullary; Humans; Hydroxyapatites; Male; Methicillin Resistance; Osteomyelitis; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Succinates; Vancomycin | 2007 |
Compaction strategies for modifying the drug delivery capabilities of gelled calcium polyphosphate matrices.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Calcium Phosphates; Compressive Strength; Drug Delivery Systems; Gels; Humans; Materials Testing; Microscopy, Electron, Scanning; Osteomyelitis; Vancomycin | 2008 |
Treatment of infection and non-union after bilateral complicated proximal tibial fracture.
Topics: Calcium Phosphates; Collagen; Female; Fracture Fixation; Fracture Fixation, Internal; Fractures, Open; Fractures, Ununited; Humans; Middle Aged; Multiple Trauma; Osteomyelitis; Postoperative Complications; Prostheses and Implants; Radiography; Tibial Fractures | 2000 |